Silence Therapeutics PLC Cash Flow-to-Debt Ratio
Silence Therapeutics PLC cash flow-to-debt ratio. Silence Therapeutics PLC (SLN) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of $1.49 Million could theoretically repay 0% of its total liabilities ($67.94 Million) in one year. Check total reinvestment intensity of Silence Therapeutics PLC to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Silence Therapeutics PLC (1995–2025)
Cash flow-to-debt ratio of Silence Therapeutics PLC from 1995 to 2025. Historical debt coverage capacity for Silence Therapeutics PLC across 31 annual periods. Check SLN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Silence Therapeutics PLC Cash Flow-to-Debt Ratio by Year (1995–2025)
Silence Therapeutics PLC cash flow-to-debt ratio by year from 1995 to 2025. Year-by-year debt coverage analysis for Silence Therapeutics PLC. For the full cash flow conversion analysis, see Silence Therapeutics PLC operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.90x | $-62.27 Million | $69.14 Million | ▲ +8.7% |
| 2024 | -0.99x | $-54.05 Million | $54.80 Million | ▼ -93.3% |
| 2023 | -0.51x | $-39.35 Million | $77.12 Million | ▲ +23.6% |
| 2022 | -0.67x | $-57.04 Million | $85.43 Million | ▼ -737.3% |
| 2021 | 0.10x | $9.19 Million | $87.67 Million | ▲ +174.8% |
| 2020 | -0.14x | $-10.78 Million | $76.91 Million | ▼ -304.2% |
| 2019 | 0.07x | $1.73 Million | $25.17 Million | ▲ +101.6% |
| 2018 | -4.38x | $-16.76 Million | $3.83 Million | ▼ -21.1% |
| 2017 | -3.61x | $-9.60 Million | $2.66 Million | ▲ +42.2% |
| 2016 | -6.25x | $-10.07 Million | $1.61 Million | ▲ +15.3% |
| 2015 | -7.38x | $-8.26 Million | $1.12 Million | ▼ -57.2% |
| 2014 | -4.70x | $-9.46 Million | $2.01 Million | ▼ -19.9% |
| 2013 | -3.92x | $-6.76 Million | $1.72 Million | ▲ +22.9% |
| 2012 | -5.08x | $-4.88 Million | $959.00K | ▼ -25.4% |
| 2011 | -4.06x | $-5.11 Million | $1.26 Million | ▲ +35.2% |
| 2010 | -6.26x | $-10.55 Million | $1.69 Million | ▼ -183.2% |
| 2009 | -2.21x | $-4.65 Million | $2.10 Million | ▲ +70.4% |
| 2008 | -7.47x | $-6.98 Million | $935.00K | ▼ -251.0% |
| 2007 | -2.13x | $-3.83 Million | $1.80 Million | ▲ +44.9% |
| 2006 | -3.86x | $-4.03 Million | $1.04 Million | ▼ -106.1% |
| 2005 | -1.87x | $-2.78 Million | $1.49 Million | ▲ +36.1% |
| 2004 | -2.93x | $-2.48 Million | $846.00K | ▼ -88.2% |
| 2003 | -1.56x | $-2.04 Million | $1.31 Million | ▲ +13.0% |
| 2002 | -1.79x | $-1.84 Million | $1.03 Million | ▲ +43.1% |
| 2001 | -3.15x | $-2.28 Million | $725.00K | ▼ -6.1% |
| 2000 | -2.97x | $-2.86 Million | $964.00K | ▼ -319.4% |
| 1999 | -0.71x | $-1.13 Million | $1.60 Million | ▲ +76.4% |
| 1998 | -3.00x | $-1.81 Million | $603.00K | ▼ -26.3% |
| 1997 | -2.37x | $-1.52 Million | $640.00K | ▼ -36.1% |
| 1996 | -1.74x | $-727.00K | $417.00K | ▲ +31.0% |
| 1995 | -2.53x | $-761.00K | $301.00K | — |